| SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing K Zhu, PJ Lei, LG Ju, X Wang, K Huang, B Yang, C Shao, Y Zhu, G Wei, ... Nucleic acids research 45 (1), 92-105, 2017 | 82 | 2017 |
| Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model QY Zhao, PJ Lei, X Zhang, JY Zheng, HY Wang, J Zhao, YM Li, M Ye, L Li, ... Clinical epigenetics 8, 1-15, 2016 | 78 | 2016 |
| Progression of metastasis through lymphatic system H Zhou, P Lei, TP Padera Cells 10 (3), 627, 2021 | 60 | 2021 |
| The hyper-activation of transcriptional enhancers in breast cancer QL Li, DY Wang, LG Ju, J Yao, C Gao, PJ Lei, LY Li, XL Zhao, M Wu Clinical epigenetics 11, 1-17, 2019 | 54 | 2019 |
| Solid stress impairs lymphocyte infiltration into lymph-node metastases D Jones, Z Wang, IX Chen, S Zhang, R Banerji, PJ Lei, H Zhou, V Xiao, ... Nature biomedical engineering 5 (12), 1426-1436, 2021 | 44 | 2021 |
| The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death JD Fan, PJ Lei, JY Zheng, X Wang, S Li, H Liu, YL He, ZN Wang, G Wei, ... PLoS One 10 (1), e0116782, 2015 | 36 | 2015 |
| The EZH1–SUZ12 complex positively regulates the transcription of NF-κB target genes through interaction with UXT SK Su, CY Li, PJ Lei, X Wang, QY Zhao, Y Cai, Z Wang, L Li, M Wu Journal of cell science 129 (12), 2343-2353, 2016 | 35 | 2016 |
| DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers S Li, C Xu, Y Fu, PJ Lei, Y Yao, W Yang, Y Zhang, MP Washburn, ... Nucleic acids research 46 (21), 11202-11213, 2018 | 29 | 2018 |
| TTLL12 inhibits the activation of cellular antiviral signaling through interaction with VISA/MAVS LG Ju, Y Zhu, PJ Lei, D Yan, K Zhu, X Wang, QL Li, XJ Li, JW Chen, LY Li, ... The Journal of Immunology 198 (3), 1274-1284, 2017 | 22 | 2017 |
| GLIS2 promotes colorectal cancer through repressing enhancer activation J Yao, PJ Lei, QL Li, J Chen, SB Tang, Q Xiao, X Lin, X Wang, LY Li, ... Oncogenesis 9 (5), 57, 2020 | 21 | 2020 |
| Epigenomic analysis in a cell-based model reveals the roles of H3K9me3 in breast cancer transformation QL Li, PJ Lei, QY Zhao, L Li, G Wei, M Wu Epigenomics 9 (8), 1077-1092, 2017 | 16 | 2017 |
| Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes PJ Lei, ER Pereira, P Andersson, Z Amoozgar, JW Van Wijnbergen, ... Journal of Experimental Medicine 220 (9), e20221847, 2023 | 6 | 2023 |
| Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells Z Amoozgar, J Ren, N Wang, P Andersson, GB Ferraro, S Krishnan, ... bioRxiv, 2022.09. 03.506476, 2022 | 5 | 2022 |
| Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy J Chen, Z Amoozgar, X Liu, S Aoki, Z Liu, SM Shin, A Matsui, ... Cancer Immunology Research, OF1-OF13, 2024 | 2 | 2024 |
| Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma R Jain, S Krishnan, S Lee, Z Amoozgar, S Subudhi, A Kumar, J Posada, ... | 1 | 2023 |
| Lymphatic muscle cells are unique cells that undergo aging induced changes PJ Lei, KJ Ruscic, K Roh, JJ Rajotte, MJ O'Melia, EM Bouta, M Marquez, ... bioRxiv, 2023.11. 18.567621, 2023 | 1 | 2023 |
| Regeneration of collecting lymphatic vessels following injury MS Razavi, PJ Lei, Z Amoozgar, N Leartprapun, SK Nadkarni, JW Baish, ... Research Square, 2023 | 1 | 2023 |
| Cancer immunotherapy responses persist after lymph node resection H Zhou, JW Baish, MJ O'Melia, LB Darragh, E Specht, J Czapla, P Lei, ... bioRxiv, 2023.09. 19.558262, 2023 | 1 | 2023 |
| Abstract A104: Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity Y Sun, Z Yin, L Wu, C Yue, S Subudhi, P Lei, A Muzikansky, BR Rueda, ... Cancer Research 84 (5_Supplement_2), A104-A104, 2024 | | 2024 |
| Abstract PR-004: Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma TP Uccello, J Ren, Z Amoozgar, Y Zhao, PJ Lei, WW Ho, S Roberge, ... Cancer Research 84 (5_Supplement_1), PR-004-PR-004, 2024 | | 2024 |
